Skip to main content

Actelion Pharmaceuticals U.S., Inc.

Recalls

Recalls by year

A bar chart of the number of recalls naming this company by year.

Recalls by year
YearRecalls
20131
Download CSV

FDA Recall Terminated Historical recordClass III

Ventavis (iloprost) Inhalation Solution, 10 mcg/1 mL, Sterile, 30 Single Use Ampules per carton, Manufactured for Actelion Pharmaceuticals US, Inc, 5000 Shoreline Court, Ste 200, South San Francisco, CA 94080, NDC: 66215-302-30.

by Actelion Pharmaceuticals U.S., Inc.

Reason
Subpotent Drug: OOS (out of specification) assay result at the 12 month stability time point.
Published
February 13, 2013
Distribution
CA & VA

View recall →

Showing 1–1 of 1 results

This page lists recalls that name Actelion Pharmaceuticals U.S., Inc. as the recalling firm in the official source notice. It is not a safety rating, ranking, or statement that the company acted negligently. Read the full medical disclaimer.